United Kingdom (UK) AI In Oncology Market (2025-2031) | Analysis, Trends, Forecast, Size & Revenue, Competitive Landscape, Share, Value, Growth, Segmentation, Industry, Companies, Outlook

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) AI In Oncology Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) AI In Oncology Market - Industry Life Cycle

3.4 United Kingdom (UK) AI In Oncology Market - Porter's Five Forces

3.5 United Kingdom (UK) AI In Oncology Market Revenues & Volume Share, By Component Type, 2021 & 2031F

3.6 United Kingdom (UK) AI In Oncology Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F

3.7 United Kingdom (UK) AI In Oncology Market Revenues & Volume Share, By Application, 2021 & 2031F

3.8 United Kingdom (UK) AI In Oncology Market Revenues & Volume Share, By End-use Type, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer cases in the UK, driving the adoption of AI in oncology for early detection and personalized treatment.

4.2.2 Technological advancements and investments in AI technologies and healthcare infrastructure by the UK government and private sector.

4.2.3 Rising demand for precision medicine and targeted therapies in oncology, leading to the integration of AI solutions for better patient outcomes.

4.3 Market Restraints

4.3.1 Data privacy and security concerns related to patient health information used in AI algorithms, hindering widespread adoption.

4.3.2 Lack of standardization and regulation in the AI in oncology market in the UK, leading to uncertainty among healthcare providers and patients.

4.3.3 High initial costs associated with implementing AI solutions in oncology practices, limiting accessibility for smaller healthcare facilities.

6.1 United Kingdom (UK) AI In Oncology Market, By Component Type

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) AI In Oncology Market Revenues & Volume, By Component Type, 2021- 2031F

6.1.3 United Kingdom (UK) AI In Oncology Market Revenues & Volume, By Software Solutions, 2021- 2031F

6.1.4 United Kingdom (UK) AI In Oncology Market Revenues & Volume, By Hardware, 2021- 2031F

6.1.5 United Kingdom (UK) AI In Oncology Market Revenues & Volume, By Services, 2021- 2031F

6.2 United Kingdom (UK) AI In Oncology Market, By Cancer Type

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) AI In Oncology Market Revenues & Volume, By Breast Cancer, 2021- 2031F

6.2.3 United Kingdom (UK) AI In Oncology Market Revenues & Volume, By Lung Cancer, 2021- 2031F

6.2.4 United Kingdom (UK) AI In Oncology Market Revenues & Volume, By Prostate Cancer, 2021- 2031F

6.2.5 United Kingdom (UK) AI In Oncology Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F

6.2.6 United Kingdom (UK) AI In Oncology Market Revenues & Volume, By Brain TumorOthers, 2021- 2031F

6.3 United Kingdom (UK) AI In Oncology Market, By Application

6.3.1 Overview and Analysis

6.3.2 United Kingdom (UK) AI In Oncology Market Revenues & Volume, By Diagnostics (Pathology, Cancer Radiology), 2021- 2031F

6.3.3 United Kingdom (UK) AI In Oncology Market Revenues & Volume, By Radiation Therapy (Radiotherapy), 2021- 2031F

6.3.4 United Kingdom (UK) AI In Oncology Market Revenues & Volume, By Research & Development (Drug design, development process, etc.), 2021- 2031F

6.3.5 United Kingdom (UK) AI In Oncology Market Revenues & Volume, By Chemotherapy, 2021- 2031F

6.3.6 United Kingdom (UK) AI In Oncology Market Revenues & Volume, By Immunotherapy, 2021- 2031F

6.4 United Kingdom (UK) AI In Oncology Market, By End-use Type

6.4.1 Overview and Analysis

6.4.2 United Kingdom (UK) AI In Oncology Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 United Kingdom (UK) AI In Oncology Market Revenues & Volume, By Surgical Centers & Medical Institutes, 2021- 2031F

6.4.4 United Kingdom (UK) AI In Oncology Market Revenues & Volume, By Others, 2021- 2031F

7.1 United Kingdom (UK) AI In Oncology Market Export to Major Countries

7.2 United Kingdom (UK) AI In Oncology Market Imports from Major Countries

8.1 Patient survival rates and outcomes post AI-assisted treatments in oncology.

8.2 Reduction in treatment time and improved accuracy of diagnosis using AI algorithms.

8.3 Adoption rate of AI tools and platforms by healthcare providers in the UK oncology sector.

9.1 United Kingdom (UK) AI In Oncology Market Opportunity Assessment, By Component Type, 2021 & 2031F

9.2 United Kingdom (UK) AI In Oncology Market Opportunity Assessment, By Cancer Type, 2021 & 2031F

9.3 United Kingdom (UK) AI In Oncology Market Opportunity Assessment, By Application, 2021 & 2031F

9.4 United Kingdom (UK) AI In Oncology Market Opportunity Assessment, By End-use Type, 2021 & 2031F

10.1 United Kingdom (UK) AI In Oncology Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) AI In Oncology Market Competitive Benchmarking, By Operating and Technical Parameters